Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dory Jewelewicz

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
The Journal of Trauma|April 17, 2002
Early use of recombinant factor VIIa improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock: a pilot studyMauricio Lynn, Igor Jerokhimov, Dory Jewelewicz, et al.
The Journal of Trauma|December 13, 2002
Early injection of high-dose recombinant factor VIIa decreases blood loss and prolongs time from injury to death in experimental liver injuryIgor Jeroukhimov, Dory Jewelewicz, Julia Zaias, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
The Journal of Trauma|April 17, 2002
Early use of recombinant factor VIIa improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock: a pilot studyMauricio Lynn, Igor Jerokhimov, Dory Jewelewicz, et al.
The Journal of Trauma|December 13, 2002
Early injection of high-dose recombinant factor VIIa decreases blood loss and prolongs time from injury to death in experimental liver injuryIgor Jeroukhimov, Dory Jewelewicz, Julia Zaias, et al.
Pageof 1